Douglas Hirsch's most recent trade in GoodRx Holdings Inc - Ordinary Shares - Class A was a trade of 10,950 Class A Common Stock done . Disclosure was reported to the exchange on Jan. 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2026 | 10,950 | 242,860 | - | 0 | Class A Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Oct 2025 | 20,521 | 231,909 | - | - | Class A Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Oct 2025 | 20,521 | 41,042 | - | - | Restricted Stock Unit | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 57,050 | 211,388 | - | 0 | Class A Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 6,392 | 154,338 | - | 0 | Class A Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Oct 2024 | 61,563 | 61,563 | - | - | Restricted Stock Unit | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Oct 2024 | 20,597 | 147,946 | - | 0 | Class A Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Oct 2024 | 797 | 127,349 | - | 0 | Class A Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Chief Mission Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 256,595 | 256,595 | - | - | Class B Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Chief Mission Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 256,595 | 0 | - | - | Restricted Stock Unit | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Chief Mission Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Sep 2024 | 130,043 | 126,552 | - | - | Class B Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Chief Mission Officer | 01 Sep 2024 | 126,552 | 126,552 | - | 0 | Class A Common Stock | ||
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Chief Mission Officer | 01 Sep 2024 | 126,552 | 0 | - | - | Class B Common Stock | ||
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Chief Mission Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Jun 2024 | 2,632,721 | 0 | - | 0 | Class A Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Chief Mission Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Jun 2024 | 2,632,721 | 2,632,721 | - | 0 | Class A Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Chief Mission Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Jun 2024 | 2,632,721 | 2,632,721 | - | 0 | Class A Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Chief Mission Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Jun 2024 | 2,632,721 | 0 | - | 0 | Class A Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Chief Mission Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Jun 2024 | 2,632,721 | 2,632,721 | - | 0 | Class A Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Chief Mission Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Jun 2024 | 2,632,721 | 2,632,721 | - | 0 | Class A Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Chief Mission Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 256,594 | 256,594 | - | - | Class B Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Chief Mission Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 256,594 | 256,595 | - | - | Restricted Stock Unit | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Chief Mission Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Jun 2024 | 130,042 | 126,552 | - | - | Class B Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Chief Mission Officer | 01 Jun 2024 | 126,552 | 5,265,442 | - | 0 | Class A Common Stock | ||
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Chief Mission Officer | 01 Jun 2024 | 126,552 | 0 | - | - | Class B Common Stock | ||
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Chief Mission Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 256,595 | 256,595 | - | - | Class B Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Chief Mission Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 256,595 | 513,189 | - | - | Restricted Stock Unit | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Chief Mission Officer | 01 Mar 2024 | 145,258 | 5,138,890 | - | 0 | Class A Common Stock | ||
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Chief Mission Officer | 01 Mar 2024 | 145,258 | 0 | - | - | Class B Common Stock | ||
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Chief Mission Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Mar 2024 | 111,337 | 145,258 | - | - | Class B Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Chief Mission Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2023 | 256,594 | 769,784 | - | - | Restricted Stock Unit | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Chief Mission Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2023 | 256,594 | 256,594 | - | - | Class B Common Stock | |
| GoodRx Holdings Inc (Class A) | Hirsch Douglas | Director, Chief Mission Officer | 01 Dec 2023 | 129,374 | 4,993,632 | - | 0 | Class A Common Stock | ||
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Chief Mission Officer | 01 Dec 2023 | 129,374 | 0 | - | - | Class B Common Stock | ||
| GoodRx Holdings Inc (Class A) | Hirsch Douglas | Director, Chief Mission Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Dec 2023 | 127,220 | 129,374 | - | - | Class B Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Chief Mission Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 256,594 | 1,282,973 | - | - | Restricted Stock Unit | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Chief Mission Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 256,594 | 256,594 | - | - | Class B Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Chief Mission Officer | 01 Jun 2023 | 129,374 | 940,081 | - | 0 | Class A Common Stock | ||
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Chief Mission Officer | 01 Jun 2023 | 129,374 | 0 | - | - | Class B Common Stock | ||
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Chief Mission Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Jun 2023 | 127,220 | 129,374 | - | - | Class B Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 256,595 | 1,539,567 | - | - | Restricted Stock Unit | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 256,595 | 256,595 | - | - | Class B Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | 01 Mar 2023 | 156,900 | 0 | - | - | Class B Common Stock | ||
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | 01 Mar 2023 | 156,900 | 810,707 | - | 0 | Class A Common Stock | ||
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Mar 2023 | 99,695 | 156,900 | - | - | Class B Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 256,594 | 1,796,162 | - | - | Restricted Stock Unit | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 256,594 | 256,594 | - | - | Class B Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | 01 Dec 2022 | 129,374 | 0 | - | - | Class B Common Stock | ||
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | 01 Dec 2022 | 129,374 | 653,807 | - | 0 | Class A Common Stock | ||
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Dec 2022 | 127,220 | 129,374 | - | - | Class B Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 256,594 | 2,052,756 | - | - | Restricted Stock Unit | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 256,594 | 256,594 | - | - | Class B Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | 01 Sep 2022 | 129,374 | 0 | - | - | Class B Common Stock | ||
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | 01 Sep 2022 | 129,374 | 524,433 | - | 0 | Class A Common Stock | ||
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Sep 2022 | 127,220 | 129,374 | - | - | Class B Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 256,595 | 256,595 | - | - | Class B Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 256,595 | 2,309,350 | - | - | Restricted Stock Unit | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | 01 Jun 2022 | 129,375 | 0 | - | - | Class B Common Stock | ||
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | 01 Jun 2022 | 129,375 | 395,059 | - | 0 | Class A Common Stock | ||
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Jun 2022 | 127,220 | 129,375 | - | - | Class B Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 256,594 | 2,565,945 | - | - | Restricted Stock Unit | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 256,594 | 256,594 | - | - | Class B Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | 01 Mar 2022 | 134,716 | 0 | - | - | Class B Common Stock | ||
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | 01 Mar 2022 | 134,716 | 265,684 | - | 0 | Class A Common Stock | ||
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Mar 2022 | 121,878 | 134,716 | - | - | Class B Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Sale of securities on an exchange or to another person at price $ 37.64 per share. | 15 Dec 2021 | 51,363 | 146,418 | - | 37.6 | 1,933,211 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Sale of securities on an exchange or to another person at price $ 36.56 per share. | 15 Dec 2021 | 42,437 | 197,781 | - | 36.6 | 1,551,391 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Sale of securities on an exchange or to another person at price $ 35.43 per share. | 15 Dec 2021 | 20,125 | 240,218 | - | 35.4 | 712,993 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Sale of securities on an exchange or to another person at price $ 38.47 per share. | 15 Dec 2021 | 10,550 | 135,868 | - | 38.5 | 405,891 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Sale of securities on an exchange or to another person at price $ 39.49 per share. | 15 Dec 2021 | 4,900 | 130,968 | - | 39.5 | 193,520 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2021 | 256,595 | 2,822,539 | - | - | Restricted Stock Unit | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2021 | 256,595 | 256,595 | - | - | Class B Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | 01 Dec 2021 | 129,375 | 0 | - | - | Class B Common Stock | ||
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | 01 Dec 2021 | 129,375 | 260,343 | - | 0 | Class A Common Stock | ||
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Dec 2021 | 127,220 | 129,375 | - | - | Class B Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Sale of securities on an exchange or to another person at price $ 44.24 per share. | 24 Sep 2021 | 116,557 | 143,785 | - | 44.2 | 5,156,493 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Sale of securities on an exchange or to another person at price $ 45.30 per share. | 24 Sep 2021 | 6,165 | 137,620 | - | 45.3 | 279,271 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Sale of securities on an exchange or to another person at price $ 42.95 per share. | 24 Sep 2021 | 5,452 | 131,468 | - | 42.9 | 234,162 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Sale of securities on an exchange or to another person at price $ 46.18 per share. | 24 Sep 2021 | 700 | 136,920 | - | 46.2 | 32,329 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Sale of securities on an exchange or to another person at price $ 43.57 per share. | 24 Sep 2021 | 500 | 130,968 | - | 43.6 | 21,783 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 256,594 | 3,079,134 | - | - | Restricted Stock Unit | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 256,594 | 256,594 | - | - | Class B Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | 01 Sep 2021 | 129,374 | 0 | - | - | Class B Common Stock | ||
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | 01 Sep 2021 | 129,374 | 391,408 | - | 0 | Class A Common Stock | ||
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Sep 2021 | 127,220 | 127,220 | - | - | Class B Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Sale of securities on an exchange or to another person at price $ 38.49 per share. | 24 Jun 2021 | 34,760 | 262,034 | - | 38.5 | 1,337,815 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Sale of securities on an exchange or to another person at price $ 38.32 per share. | 23 Jun 2021 | 56,133 | 296,794 | - | 38.3 | 2,150,809 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Sale of securities on an exchange or to another person at price $ 37.49 per share. | 23 Jun 2021 | 38,482 | 352,927 | - | 37.5 | 1,442,652 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 256,595 | 3,335,728 | - | - | Restricted Stock Unit | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 256,595 | 256,595 | - | - | Class B Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | 01 Jun 2021 | 129,375 | 391,409 | - | 0 | Class A Common Stock | ||
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | 01 Jun 2021 | 129,375 | 0 | - | - | Class B Common Stock | ||
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Jun 2021 | 127,220 | 129,375 | - | - | Class B Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Sale of securities on an exchange or to another person at price $ 37.39 per share. | 22 Mar 2021 | 67,199 | 130,968 | - | 37.4 | 2,512,349 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Sale of securities on an exchange or to another person at price $ 36.91 per share. | 22 Mar 2021 | 62,867 | 198,167 | - | 36.9 | 2,320,434 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director, Co-CEO | Sale of securities on an exchange or to another person at price $ 35.58 per share. | 22 Mar 2021 | 1,000 | 261,034 | - | 35.6 | 35,581 | Class A Common Stock |